Navigation Links
Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
Date:10/29/2008

DANVILLE, Calif., Oct. 29 /PRNewswire/ -- On December 5, 2008, Alta Bates Summit Medical Center's Markstein Cancer Services will hold a colorectal cancer screening at their Summit Campus (3100 Summit Street, Oakland, CA, 94609). This community cancer screening is sponsored by Lazarex Cancer Foundation, a San Francisco Bay Area non-profit dedicated to changing the face of cancer, one life at a time. Sponsoring this screening is part of the organization's mission to revitalize cancer patients and their families with promising treatments, compassionate care, and comprehensive wellness products and services.

Colorectal cancer is the second leading cause of cancer in the United States. Early detection and removal of a precancerous polyp can prevent colorectal cancer.

This past year, Lazarex has helped end-stage patients successfully fight a variety of cancers, including breast, pancreatic and brain cancers, in addition to funding screenings such as this one through the Markstein Cancer Services at Alta Bates Summit Medical Center. "Both Lazarex Cancer Foundation and Markstein Cancer Services share a common goal of stopping the enemy before it starts by preventing new cases of cancer," said Lazarex Cancer Foundation President Dana Dornsife.

In order to participate in this community colorectal cancer screening, individuals must complete several steps, including obtaining a referral from their doctor, making an appointment with the Alta Bates Summit Medical Center's Markstein Cancer Services, and completing mandatory preparation steps 24 hours prior to the procedure on Dec. 5th. Partial and complete funding is available for eligible individuals. For more information, please contact Leslie Paine at Alta Bates Summit Medical Center, 510.869.8833 or PaineL@sutterhealth.org.

About Lazarex Cancer Foundation

Lazarex Cancer Foundation, a volunteer-run organization, creates a lifeline-a bridge to hope, life and dignity-for cancer patients and their families. The Foundation supports cancer patients who have been failed by conventional medicine by providing financial assistance for, and access to, new and promising FDA clinical trials. We believe that together, we can change the face of cancer, one life at a time. To find out more about how you can get involved, contact Lazarex Cancer Foundation at 925.820.4517 or visit http://www.lazarexfoundation.org.


'/>"/>
SOURCE Lazarex Cancer Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... 26, 2017 , ... Global healthcare company Novo Nordisk, renewed ... company’s commitment to the world’s first all-diabetes professional cycling team to a total ... partnered with the professional cycling team Team Type 1 to create Team Novo ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... CGL Electronic ... first office under its new umbrella, CGL Technologies, LLC. , The new CGL Technologies, ... veterans Remo Patitucci and Jon McCormack, both of whom have creative business development methods, ...
(Date:9/26/2017)... ... September 26, 2017 , ... As the holiday season nears, ... https://dealfeed.sutlr.com . People are constantly trying to find tips and stories for products and ... feed brings you the top trending deals. The deals are organized by categories so ...
(Date:9/26/2017)... ... September 26, 2017 , ... ... Device Manufacturers, **An FDAnews Management Report**, http://www.fdanews.com/products/54648-principles-of-equipment-qualification      , ... Manufacturers must prove that their equipment, operations and processes all work the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Founded as ... decades growing into an innovative leader in special education. In 2018, Glenholme will ... , Glenholme, formerly a world renowned horse farm for Hackney show ponies, was generously ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
(Date:9/5/2017)... 5, 2017 Sapheneia and Scannerside received FDA ... DoseCheck is a third-party Vendor neutral CT product that ... allows compliance with current MITA standards. ... DoseCheck solution is specifically designed to provide CT operators, ... radiation doses over a predefined threshold. Scannerside Dose Check ...
(Date:9/5/2017)... WAYNE, N.J. , Sept. 5, 2017 /PRNewswire/ ... technology, has created a vibrant charitable donation program ... funds and support congenital heart defect research by ... healthcare providers and the general public are encouraged ... and submit the completed artwork to the ...
Breaking Medicine Technology: